Reference:
1. Marian AJ, Braunwald E. Hypertrophic Cardiomyopathy: Genetics,
Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res.
2017;121(7):749-70.
2. Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron
P, et al. 2014 ESC Guidelines on diagnosis and management of
hypertrophic cardiomyopathy: the Task Force for the Diagnosis and
Management of Hypertrophic Cardiomyopathy of the European Society of
Cardiology (ESC). Eur Heart J. 2014;35(39):2733-79.
3. Ommen SR, Mital S, Burke MA, Day SM, Deswal A, Elliott P, et al. 2020
AHA/ACC Guideline for the Diagnosis and Treatment of Patients With
Hypertrophic Cardiomyopathy: A Report of the American College of
Cardiology/American Heart Association Joint Committee on Clinical
Practice Guidelines. Circulation. 2020;142(25):e558-e631.
4. Wang Y, Wang J, Zou Y, Bao J, Sun K, Zhu L, et al. Female Sex Is
Associated with Worse Prognosis in Patients with Hypertrophic
Cardiomyopathy in China. PLOS ONE. 2014;9(7):e102969.
5. Zaiser E, Sehnert AJ, Duenas A, Saberi S, Brookes E, Reaney M.
Patient experiences with hypertrophic cardiomyopathy: a conceptual model
of symptoms and impacts on quality of life. Journal of Patient-Reported
Outcomes. 2020;4(1):102.
6. Siontis KC, Geske JB, Ong K, Nishimura RA, Ommen SR, Gersh BJ. Atrial
fibrillation in hypertrophic cardiomyopathy: prevalence, clinical
correlations, and mortality in a large high-risk population. J Am Heart
Assoc. 2014;3(3):e001002.
7. Maron BJ, Olivotto I, Bellone P, Conte MR, Cecchi F, Flygenring BP,
et al. Clinical profile of stroke in 900 patients with hypertrophic
cardiomyopathy. J Am Coll Cardiol. 2002;39(2):301-7.
8. Elliott PM, Gimeno JR, Thaman R, Shah J, Ward D, Dickie S, et al.
Historical trends in reported survival rates in patients with
hypertrophic cardiomyopathy. Heart. 2006;92(6):785-91.
9. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE.
Prevalence of hypertrophic cardiomyopathy in a general population of
young adults. Echocardiographic analysis of 4111 subjects in the CARDIA
Study. Coronary Artery Risk Development in (Young) Adults. Circulation.
1995;92(4):785-9.
10. Maron MS, Hellawell JL, Lucove JC, Farzaneh-Far R, Olivotto I.
Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the
United States. Am J Cardiol. 2016;117(10):1651-4.
11. Maron MS. Family History of Sudden Death Should Be a Primary
Indication for Implantable Cardioverter Defibrillator in Hypertrophic
Cardiomyopathy. The Canadian journal of cardiology. 2015;31 11:1402-6.
12. Dunn K, Caleshu C, Cirino AL, Ho CY, Ashley EA. A Clinical Approach
to Inherited Hypertrophy: The Use of Family History in Diagnosis, Risk
Assessment, and Management. Circulation: Cardiovascular Genetics.
2013;6:118–31.
13. Mikic L, Ristic A, Markovic Nikolic N, Tesic M, Jakovljevic DG,
Arena R, et al. The Role of Cardiopulmonary Exercise Testing in
Hypertrophic Cardiomyopathy. Medicina. 2023;59(7):1296.
14. Mandeş L, Roşca M, Ciupercă D, Popescu BA. The role of
echocardiography for diagnosis and prognostic stratification in
hypertrophic cardiomyopathy. J Echocardiogr. 2020;18(3):137-48.
15. Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the
prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol.
2015;65(12):1249-54.
16. Rowin EJ, Maron MS, Casey SA, Link MS, Chan RH, Appelbaum E, et al.
Evidence for reduced mortality in an adult cohort with hypertrophic
cardiomyopathy. Am Heart Assoc; 2013.
17. Hardarson T, De la Calzada CS, Curiel R, Goodwin JF. Prognosis and
mortality of hypertrophic obstructive cardiomyopathy. Lancet.
1973;2(7844):1462-7.
18. Shah PM, Adelman AG, Wigle ED, Gobel FL, Burchell HB, Hardarson T,
et al. The natural (and unnatural) history of hypertrophic obstructive
cardiomyopathy. Circ Res. 1974;35(2):suppl II:179-95.
19. Spirito P, Autore C, Formisano F, Assenza GE, Biagini E, Haas TS, et
al. Risk of sudden death and outcome in patients with hypertrophic
cardiomyopathy with benign presentation and without risk factors. Am J
Cardiol. 2014;113(9):1550-5.
20. Maron BJ, Rowin EJ, Casey SA, Haas TS, Chan RH, Udelson JE, et al.
Risk stratification and outcome of patients with hypertrophic
cardiomyopathy >=60 years of age. Circulation.
2013;127(5):585-93.
21. Rowin EJ, Hausvater A, Link MS, Abt P, Gionfriddo W, Wang W, et al.
Clinical Profile and Consequences of Atrial Fibrillation in Hypertrophic
Cardiomyopathy. Circulation. 2017;136(25):2420-36.
22. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al.
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic
cardiomyopathy: a report of the American College of Cardiology
Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2011;124(24):e783-831.
23. Williams LK, Frenneaux MP, Steeds RP. Echocardiography in
hypertrophic cardiomyopathy diagnosis, prognosis, and role in
management. Eur J Echocardiogr. 2009;10(8):iii9-14.
24. World Medical Association Declaration of Helsinki: ethical
principles for medical research involving human subjects. Jama.
2013;310(20):2191-4.
25. Aro AL, Nair SG, Reinier K, Jayaraman R, Stecker EC, Uy-Evanado A,
et al. Population Burden of Sudden Death Associated With Hypertrophic
Cardiomyopathy. Circulation. 2017;136(17):1665-7.
26. Cannan CR, Reeder GS, Bailey KR, Melton LJ, 3rd, Gersh BJ. Natural
history of hypertrophic cardiomyopathy. A population-based study, 1976
through 1990. Circulation. 1995;92(9):2488-95.
27. Kofflard MJ, Waldstein DJ, Vos J, ten Cate FJ. Prognosis in
hypertrophic cardiomyopathy observed in a large clinic population. Am J
Cardiol. 1993;72(12):939-43.
28. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden Deaths
in Young Competitive Athletes. Circulation. 2009;119(8):1085-92.
29. Udelson JE, Bonow RO, O’Gara PT, Maron BJ, Van Lingen A, Bacharach
SL, et al. Verapamil prevents silent myocardial perfusion abnormalities
during exercise in asymptomatic patients with hypertrophic
cardiomyopathy. Circulation. 1989;79(5):1052-60.
30. O’Gara PT, Bonow RO, Maron BJ, Damske BA, Van Lingen A, Bacharach
SL, et al. Myocardial perfusion abnormalities in patients with
hypertrophic cardiomyopathy: assessment with thallium-201 emission
computed tomography. Circulation. 1987;76(6):1214-23.
31. Rowin EJ, Maron MS, Chan RH, Hausvater A, Wang W, Rastegar H, et al.
Interaction of Adverse Disease Related Pathways in Hypertrophic
Cardiomyopathy. Am J Cardiol. 2017;120(12):2256-64.
32. Kofflard MJ, Ten Cate FJ, van der Lee C, van Domburg RT.
Hypertrophic cardiomyopathy in a large community-based population:
clinical outcome and identification of risk factors for sudden cardiac
death and clinical deterioration. J Am Coll Cardiol. 2003;41(6):987-93.
33. Miller EM, Wang Y, Ware SM. Uptake of cardiac screening and genetic
testing among hypertrophic and dilated cardiomyopathy families. J Genet
Couns. 2013;22(2):258-67.
34. Tomašov P, Minárik M, Zemánek D, Čadová P, Homolová S, Čurilka K, et
al. Genetic testing in the management of relatives of patients with
hypertrophic cardiomyopathy. Folia Biol (Praha). 2014;60(1):28-34.
35. Burns J, Jean-Pierre P. Disparities in the diagnosis of hypertrophic
obstructive cardiomyopathy: a narrative review of current literature.
Cardiology Research and Practice. 2018;2018.
36. Sankaranarayanan R, E JF, C JG. Mimics of Hypertrophic
Cardiomyopathy - Diagnostic Clues to Aid Early Identification of
Phenocopies. Arrhythm Electrophysiol Rev. 2013;2(1):36-40.
37. Licordari R, Trimarchi G, Teresi L, Restelli D, Lofrumento F, Perna
A, et al. Cardiac Magnetic Resonance in HCM Phenocopies: From Diagnosis
to Risk Stratification and Therapeutic Management. J Clin Med.
2023;12(10).
38. Marian AJ. Hypertrophic cardiomyopathy: from genetics to treatment.
Eur J Clin Invest. 2010;40(4):360-9.
39. Nienaber CA, Hiller S, Spielmann RP, Geiger M, Kuck KH. Syncope in
hypertrophic cardiomyopathy: multivariate analysis of prognostic
determinants. J Am Coll Cardiol. 1990;15(5):948-55.
40. Elsouri KN, Camacho Ramos J, Stepanek K, Turan A, Kesselman MM,
Demory ML. Adult Onset Hypertrophic Cardiomyopathy (HCM) Not Detected by
Echocardiogram: A Case Presentation. Cureus. 2023;15(9):e45932.